Annual CFO
-$52.07 M
-$6.21 M-13.54%
December 31, 2023
Summary
- As of February 8, 2025, JSPR annual cash flow from operations is -$52.07 million, with the most recent change of -$6.21 million (-13.54%) on December 31, 2023.
- During the last 3 years, JSPR annual CFO has fallen by -$33.80 million (-185.03%).
- JSPR annual CFO is now -185.03% below its all-time high of -$18.27 million, reached on December 31, 2020.
Performance
JSPR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$14.05 M
-$2.37 M-20.31%
September 30, 2024
Summary
- As of February 8, 2025, JSPR quarterly cash flow from operations is -$14.05 million, with the most recent change of -$2.37 million (-20.31%) on September 30, 2024.
- Over the past year, JSPR quarterly CFO has dropped by -$2.07 million (-17.29%).
- JSPR quarterly CFO is now -142.65% below its all-time high of -$5.79 million, reached on June 30, 2021.
Performance
JSPR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$57.95 M
-$2.07 M-3.71%
September 30, 2024
Summary
- As of February 8, 2025, JSPR TTM cash flow from operations is -$57.95 million, with the most recent change of -$2.07 million (-3.71%) on September 30, 2024.
- Over the past year, JSPR TTM CFO has dropped by -$9.71 million (-20.14%).
- JSPR TTM CFO is now -835.38% below its all-time high of -$6.20 million, reached on March 31, 2021.
Performance
JSPR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
JSPR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.5% | -17.3% | -20.1% |
| 3 y3 years | -185.0% | -17.3% | -20.1% |
| 5 y5 years | -185.0% | -17.3% | -20.1% |
JSPR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.6% | at low | -50.2% | +14.7% | -72.1% | at low |
| 5 y | 5-year | -185.0% | at low | -142.7% | +14.7% | -835.4% | at low |
| alltime | all time | -185.0% | at low | -142.7% | +14.7% | -835.4% | at low |
Jasper Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.05 M(+20.3%) | -$57.95 M(+3.7%) |
| Jun 2024 | - | -$11.68 M(-25.8%) | -$55.88 M(-2.8%) |
| Mar 2024 | - | -$15.74 M(-4.5%) | -$57.47 M(+10.4%) |
| Dec 2023 | -$52.07 M(+13.5%) | -$16.48 M(+37.5%) | -$52.07 M(+7.9%) |
| Sep 2023 | - | -$11.98 M(-9.7%) | -$48.23 M(+5.1%) |
| Jun 2023 | - | -$13.27 M(+28.4%) | -$45.90 M(+9.3%) |
| Mar 2023 | - | -$10.34 M(-18.3%) | -$41.98 M(-8.5%) |
| Dec 2022 | -$45.86 M | -$12.65 M(+31.1%) | -$45.86 M(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$9.64 M(+3.1%) | -$47.80 M(+5.6%) |
| Jun 2022 | - | -$9.36 M(-34.2%) | -$45.26 M(+8.5%) |
| Mar 2022 | - | -$14.21 M(-2.5%) | -$41.70 M(+23.8%) |
| Dec 2021 | -$33.68 M(+84.4%) | -$14.58 M(+105.2%) | -$33.68 M(+76.4%) |
| Sep 2021 | - | -$7.11 M(+22.7%) | -$19.09 M(+59.3%) |
| Jun 2021 | - | -$5.79 M(-6.5%) | -$11.99 M(+93.5%) |
| Mar 2021 | - | -$6.20 M | -$6.20 M |
| Dec 2020 | -$18.27 M | - | - |
FAQ
- What is Jasper Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Jasper Therapeutics?
- What is Jasper Therapeutics annual CFO year-on-year change?
- What is Jasper Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly CFO year-on-year change?
- What is Jasper Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Jasper Therapeutics?
- What is Jasper Therapeutics TTM CFO year-on-year change?
What is Jasper Therapeutics annual cash flow from operations?
The current annual CFO of JSPR is -$52.07 M
What is the all time high annual CFO for Jasper Therapeutics?
Jasper Therapeutics all-time high annual cash flow from operations is -$18.27 M
What is Jasper Therapeutics annual CFO year-on-year change?
Over the past year, JSPR annual cash flow from operations has changed by -$6.21 M (-13.54%)
What is Jasper Therapeutics quarterly cash flow from operations?
The current quarterly CFO of JSPR is -$14.05 M
What is the all time high quarterly CFO for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly cash flow from operations is -$5.79 M
What is Jasper Therapeutics quarterly CFO year-on-year change?
Over the past year, JSPR quarterly cash flow from operations has changed by -$2.07 M (-17.29%)
What is Jasper Therapeutics TTM cash flow from operations?
The current TTM CFO of JSPR is -$57.95 M
What is the all time high TTM CFO for Jasper Therapeutics?
Jasper Therapeutics all-time high TTM cash flow from operations is -$6.20 M
What is Jasper Therapeutics TTM CFO year-on-year change?
Over the past year, JSPR TTM cash flow from operations has changed by -$9.71 M (-20.14%)